Compositions containing histamine-H.sub.2 -receptor antagonists at low dosage
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 12, 1997
Grant Date -
N/A
app pub date -
Jun 15, 1994
filing date -
Dec 20, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Compositions for oral administration for the treatment of gastric disorders comprising histamine H.sub.2 -receptor antagonist, and antacid, optimally buffered to promote local absorption of the H.sub.2 -receptor antagonist, wherein the quantity of H.sub.2 -receptor antagonist per unit dosage form is less than 25 mg.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully